Literature DB >> 15476937

Effects of urocortin 2 and 3 on motor activity and food intake in rats.

Hisayuki Ohata1, Tamotsu Shibasaki.   

Abstract

Urocortin 2 (Ucn 2) and Ucn 3 are new members of the corticotropin-releasing factor (CRF) family and bind selectively to the CRF type 2 receptor (CRF2). The effects of these peptides on behavioral changes induced by CRF were examined in rats. In a familiar environment, intracerebroventricular injection of Ucn 2 attenuated the stimulatory effect of CRF on motor activity, although it alone produced no effect. Ucn 3 suppressed motor activity and attenuated the stimulatory effect of CRF. In an open field, CRF decreased locomotion and rearing but increased grooming behavior. Ucn 2 attenuated the inhibition of locomotor activity induced by CRF without affecting other activities, such as rearing or grooming behavior. Ucn 3 had no effect on the behavioral changes induced by CRF, although it alone decreased locomotion and rearing in a manner similar to CRF. Ucn 2 was thus found to have an antagonistic effect on bi-directional motor activation induced by CRF, while Ucn 3 had a suppressive effect on motor activity. Both Ucn 2 and Ucn 3 suppressed food intake in freely-fed rats, but not immediately after injection. These results suggest that the CRF2 receptor is involved in motor suppressive effects as well as anxiolytic and anorectic effects of Ucn 2 and Ucn 3.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15476937     DOI: 10.1016/j.peptides.2004.05.023

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  23 in total

1.  Type 2 corticotropin-releasing factor receptor in the ventromedial nucleus of hypothalamus is critical in regulating feeding and lipid metabolism in white adipose tissue.

Authors:  Hongxia Chao; Michael Digruccio; Peilin Chen; Chien Li
Journal:  Endocrinology       Date:  2011-11-08       Impact factor: 4.736

2.  Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.

Authors:  Eva M Fekete; Koki Inoue; Yu Zhao; Jean E Rivier; Wylie W Vale; Attila Szücs; George F Koob; Eric P Zorrilla
Journal:  Neuropsychopharmacology       Date:  2006-10-04       Impact factor: 7.853

Review 3.  Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.

Authors:  Richard L Hauger; Victoria Risbrough; Olaf Brauns; Frank M Dautzenberg
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-08       Impact factor: 4.388

4.  Urocortin 2 increases c-Fos expression in serotonergic neurons projecting to the ventricular/periventricular system.

Authors:  Matthew W Hale; Christopher E Stamper; Daniel R Staub; Christopher A Lowry
Journal:  Exp Neurol       Date:  2010-04-09       Impact factor: 5.330

5.  Effects of peripherally administered urocortin 3 on feeding behavior and gastric emptying in mice.

Authors:  Mutsumi Terashi; Akihiro Asakawa; Kai-Chun Cheng; Ken-Ichiro Koyama; Huke Chaolu; Miharu Ushikai; Akio Inui
Journal:  Exp Ther Med       Date:  2011-01-20       Impact factor: 2.447

6.  Systemic urocortin 2, but not urocortin 1 or stressin 1-A, suppresses feeding via CRF2 receptors without malaise and stress.

Authors:  E M Fekete; Y Zhao; A Szücs; V Sabino; P Cottone; J Rivier; W W Vale; G F Koob; E P Zorrilla
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

7.  Identification of urocortin 3 afferent projection to the ventromedial nucleus of the hypothalamus in rat brain.

Authors:  Peilin Chen; David Lin; Jessica Giesler; Chien Li
Journal:  J Comp Neurol       Date:  2011-07-01       Impact factor: 3.215

8.  Peripheral activation of corticotropin-releasing factor receptor 2 inhibits food intake and alters meal structures in mice.

Authors:  Lixin Wang; Andreas Stengel; Miriam Goebel; Vicente Martinez; Guillaume Gourcerol; Jean Rivier; Yvette Taché
Journal:  Peptides       Date:  2010-10-20       Impact factor: 3.750

9.  Injection of Urocortin 3 into the ventromedial hypothalamus modulates feeding, blood glucose levels, and hypothalamic POMC gene expression but not the HPA axis.

Authors:  Peilin Chen; Joan Vaughan; Cindy Donaldson; Wylie Vale; Chien Li
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-12-01       Impact factor: 4.310

10.  Differential blockade of CRF-evoked behaviors by depletion of norepinephrine and serotonin in rats.

Authors:  Owen Howard; Gregory V Carr; Tiffany E Hill; Rita J Valentino; Irwin Lucki
Journal:  Psychopharmacology (Berl)       Date:  2008-05-31       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.